JPX · 4320.T
CE Holdings Co., Ltd.
¥1,633¥0 (0.0%)
CE Holdings Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.16% below the high.
Loading market information…
JPX · 3902.T · JPY
Stock price, dividends, earnings
Quote as of Apr 23, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Medical Data Vision Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.53% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Medical Data Vision Co., Ltd.’s forward annual dividend is ¥9 per share, paid annual. The forward yield is 0.53% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Medical Data Vision Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Medical Data Vision Co., Ltd. specializes in the comprehensive development, production, maintenance, and sales of integrated medical information systems across Japan. The company's offerings also include medical data analysis, surveys, and consulting services, as well as management advisory for healthcare institutions. Furthermore, it provides dedicated medical data services and is involved in the conceptualization, development, and operation of various online portal platforms. Its broad client base encompasses pharmaceutical companies, medical device manufacturers, academic bodies, research organizations, and health insurance providers. Founded in 2003, the company maintains its headquarters in Tokyo, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:00 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2024 |
|---|
| May 13, 2024 |
| -¥0 |
| ¥1.39B+74,554.03% vs estimate |
KEEP COMPARING
¥1,633¥0 (0.0%)
CE Holdings Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.16% below the high.
¥785-¥1 (-0.13%)
SEED Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.13% below the high.
¥856+¥8 (+0.94%)
FINDEX Inc.’s quoted price sits in the lower half of its reported 52-week range, 15.33% below the high.
¥737+¥6 (+0.82%)
Medius Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.63% below the high.
¥4,975-¥10 (-0.2%)
Hoshi Iryo-Sanki Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.08% below the high.
¥749-¥17 (-2.22%)
CanBas Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 24.42% below the high.
¥1,150-¥2 (-0.17%)
Wellness Communications Corporation’s quoted price sits in the lower half of its reported 52-week range, 24.34% below the high.
¥139-¥7 (-4.79%)
StemRIM’s quoted price sits in the lower half of its reported 52-week range, 62.23% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
